CSIMarket
 


Passage Bio inc   (PASG)
Other Ticker:  
 

Cumulative Passage Bio Inc 's Leverage Ratio for Trailing Twelve Months Period

PASG's Leverage Ratio for Trailing Twelve Months Period and Total Liabilities, Equity growth


Select the Comparisons : Select the Ratio:

PASG Leverage Ratio for Trailing Twelve Months Period

(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Equity Growth -44.74 % -43.73 % -39.36 % -39.44 % -36.81 %
Y / Y Total Liabilities Growth -6.92 % -5.86 % -15.74 % -17.38 % 157.7 %
Leverage Ratio for Trailing Twelve Months Period 0.3 0.26 0.23 0.22 0.2
Total Ranking # 343 # 538 # 530 # 526 # 581
Seq. Equity Growth -11.87 % -16.05 % -11.7 % -15.4 % -10.26 %
Seq. Total Liabilities Growth -8.65 % -0.7 % 0.91 % 1.68 % -7.61 %


Leverage Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Dec 31 2023
On the trailing twelve months basis Despite debt repayement of -8.65% in IV. Quarter, Leverage Ratio for Trailing Twelve Months Period improved to 0.3, a new company high.
Leverage Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Biotechnology & Pharmaceuticals industry 25 other companies have achieved lower Leverage Ratio for Trailing Twelve Months Period than Passage Bio Inc . While total ranking remained unchanged compare to previous quarter at no. .

What is Leverage Ratio?
Who are PASG's Customers?
Leverage Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 26
Sector # 160
S&P 500 # 406


Leverage Ratio for Trailing Twelve Months Period Statistics
High Average Low
0.3 0.16 0.05
(Dec 31 2023)   (Dec 31 2020)




Companies with similar average Leverage Ratio for Trailing Twelve Months Period for 12 months ending Dec 31 2023, within Biotechnology & Pharmaceuticals Industry Leverage Ratio for Trailing Twelve Months Period
Elevation Oncology inc   0.80 
Freeline Therapeutics Holdings Plc  0.79 
Xtant Medical Holdings Inc   0.77 
Titan Pharmaceuticals Inc   0.77 
Candel Therapeutics Inc   0.75 
Beam Therapeutics Inc   0.74 
Sana Biotechnology Inc   0.74 
Century Therapeutics inc   0.73 
Sab Biotherapeutics Inc   0.72 
Omega Therapeutics Inc   0.71 
Avalon Globocare Corp   0.68 
Regenxbio Inc   0.65 
Kodiak Sciences Inc   0.64 
Sangamo Therapeutics Inc   0.64 
Lineage Cell Therapeutics Inc   0.63 
Finch Therapeutics Group Inc   0.55 
Aptose Biosciences Inc   0.55 
Immunocore Holdings Plc  0.52 
Ginkgo Bioworks Holdings Inc   0.52 
C4 Therapeutics Inc   0.52 
Erytech Pharma S a   0.52 
Zura Bio Limited  0.50 
Tcr2 Therapeutics Inc   0.49 
Qiagen N v   0.48 
Vericel Corporation  0.48 
Senti Biosciences Inc   0.47 
Surface Oncology Inc   0.47 
Gritstone Bio Inc   0.46 
Vaxart Inc   0.46 
Aligos Therapeutics Inc   0.46 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com